Infectious Disease

Company seeks to leverage technologies to address unmet needs.

Scientists solve structural details of HIV machinery.

Cancer accounts for more years of life lost than any other cause of death.

Vaccine-preventable disease death rates have decreased since 1980.

Scedosporium is a fungal pathogen that is resistant against most antifungals.

Officials with the FDA have rejected new drug applications for Cempra's community-acquired bacterial pneumonia (CABP) antibiotic, according to a press release from Cempra.

Top HIV articles of the year on Specialty Pharmacy Times.

A new study examines a different treatment strategy for pneumonia.

In this week's "Around the Web," Pharmacy Times presents a video that was recently posted by the World Health Organization, which discusses self-testing options for HIV.

Study captures major changes in infectious diseases between 1980 through 2014.

Memantine increases the risk of developing pneumonia by 1.6 times.

New progress made towards the development of an HIV vaccine.

Launch of South Africa-based clinical trial provides hope for the defeat of HIV.

The FDA Antimicrobial Drugs Advisory Committee (AMDAC) has voted 7-6 that the efficacy results of Cempra's solithromycin outweigh the risks for the treatment of community-acquired bacterial pneumonia (CABP).

The 14th Report on Carcinogens added 5 viruses and 2 substances to the list of known carcinogens.

To completely understand pneumococcal vaccines and appreciate the progress in this area, pharmacists need to review some history.

Potent antibody may prove more advantageous for HIV prevention and treatment strategies.

Stay up-to-date with the hottest news in pharmacy!

A chronic lung infection from Pseudomonas aeruginosa can be drug-resistant and cause lung tissue damage.

Respiratory syncytial virus infections can potentially be fatal for older adults and children.

Dexamethasone is an important but commonly overlooked adjunct therapy in bacterial meningitis. Learn more about this important intervention and recommend its use in the acute setting before antibiotics are given.

Funding of $24 million will support programs and studies that address HIV-infection and prevention among at-risk groups.

Less than 10% of young gay, bisexual, and other men who have sex with men have used HIV pre-exposure prophylaxis.

National Health Checkup finds that cancer beat out infectious diseases as the biggest concern.

New data suggests certain hospitalized CAP patients treated initially with oral antibiotics may not have worse outcomes compared to those initially treated with IV antibiotics.